IN HCR0044

Honors and recognizes contributions of Indiana cancer researchers and patients who participate in cancer research clinical trials.

Notes that only 3-5% of cancer patients participate in clinical trials, identifying participants as a select and altruistic group.

Acknowledges Indiana's leadership in cancer research through companies, healthcare providers, and academic centers, citing Dr. Lawrence Einhorn's work on testicular cancer at Indiana University.

Recognizes disproportionately high cancer incidence rates among Black and Hispanic populations in Indiana, while the state ranks 40th in overall cancer mortality.

Directs the House Principal Clerk to transmit the resolution to the Hoosier Oncology Group, Indiana Cancer Consortium, Indiana University Simon Cancer Center, American Cancer Society Great Lakes Division, Purdue University Cancer Center, and Eli Lilly and Company.